Zhongzhi Pharmaceutical Holdings Limited Financial Overview
Zhongzhi Pharmaceutical Holdings Limited's market cap is currently HK$482.79M. The company's EPS TTM is HK$0.011; its P/E ratio is 21.67; and it has a dividend yield of 8.77%. Zhongzhi Pharmaceutical Holdings Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
